Showing results (271-280 of 316) with videos related to
Sort By:
Pageof 32
Trials|January 21, 2018
Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) frameworkCaroline Wilson, Leila Rooshenas, Sangeetha Paramasivan, et al.Frontiers in Physiology|July 1, 2022
The Effects of Reconditioning Exercises Following Prolonged Bed Rest on Lumbopelvic Muscle Volume and Accumulation of Paraspinal Muscle FatEnrico De Martino, Julie Hides, James M Elliott, et al.Plos Medicine|May 15, 2014
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewJenni Hislop, Temitope E Adewuyi, Luke D Vale, et al.BMJ Open|November 16, 2017
Incidence of shoulder dislocations in the UK, 1995-2015: a population-based cohort studyAnjali Shah, Andrew Judge, Antonella Delmestri, et al.The Spine Journal : Official Journal of the North American Spine Society|November 23, 2021
Intramuscular lipid concentration increased in localized regions of the lumbar muscles following 60 day bedrestEnrico De Martino, Julie Hides, James M Elliott, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|July 1, 2021
Intermittent short-arm centrifugation is a partially effective countermeasure against upright balance deterioration following 60-day head-down tilt bed restEnrico De Martino, Sauro E Salomoni, Paul W Hodges, et al.Arthritis Research & Therapy|August 23, 2023
Cellular characterisation of advanced osteoarthritis knee synoviumJolet Y Mimpen, Robert Hedley, Anna Ridley, et al.Health Technology Assessment (Winchester, England)|May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewJonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.The Lancet. Rheumatology|June 28, 2024
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trialClaudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, et al.Trials|June 14, 2017
Choosing the target difference ('effect size') for a randomised controlled trial - DELTA2 guidance protocolJonathan A Cook, Steven A Julious, William Sones, et al.Pageof 32